Sepsis and serum cytokine concentrations

被引:224
作者
Damas, P
Canivet, JL
DeGroote, D
Vrindts, Y
Albert, A
Franchimont, P
Lamy, M
机构
[1] UNIV LIEGE, CTR HOSP, DEPT BIOSTAT, B-4000 LIEGE, BELGIUM
[2] UNIV LIEGE, CTR HOSP, DEPT ENDOCRINOL INTERNAL MED, B-4000 LIEGE, BELGIUM
[3] MEDGENIX, FLEURUS, BELGIUM
关键词
severe sepsis; septic shock; interleukin-6; interleukin-8; tumor necrosis factor-alpha; leukemia inhibitory factor; cytokines;
D O I
10.1097/00003246-199703000-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To look for relationships between the classification of sepsis and plasma cytokine concentrations. Design: Prospective, consecutive entry study of patients meeting severe sepsis criteria and having bacteriologically documented infections. Setting: University hospital, surgical intensive care unit. Patients: Fifty consecutive patients developing severe sepsis or septic shock between December 1991 and December 1993. Measurements and Main Results: Concentrations of tumor necrosis factor, interleukin (IL)-6, IL-8, and leukemia inhibitory factor were measured by immunoradiometric assay in the plasma of patients as soon as they developed severe sepsis or septic shock. Septic shock patients were divided into three groups in a blinded fashion (i.e., without knowing the results of the concentrations of cytokines), according to the presence of sustained hyperlactacidemia and to the rapidity of the onset of sepsis. Peak concentrations of all cytokines were statistically different between severe sepsis and septic shock patients. This finding was almost exclusively due to the data from patients with rapid onset of septic shock, who demonstrated very high but transient cytokine concentrations. Septic shock patients may thus have different profiles in the time course of their cytokine concentrations. The transient, high peak concentrations of cytokines were also related to transient leukopenia. Among the cytokines measured, IL-8 appeared to be the one that correlated best with lactacidemia, the presence of disseminated intravascular coagulation, severe hypoxemia, the Acute Physiology and Chronic Health Evaluation II score, and mortality rate. Conclusions: According to the profiles of the cytokines, septic shock patients do not represent a homogeneous population. These profiles should be described in order to distinguish between patients, and the profiles may be useful to identify those patients susceptible to new therapies.
引用
收藏
页码:405 / 412
页数:8
相关论文
共 45 条
  • [1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL
    ABRAHAM, E
    WUNDERINK, R
    SILVERMAN, H
    PERL, TM
    NASRAWAY, S
    LEVY, H
    BONE, R
    WENZEL, RP
    BALK, R
    ALLRED, R
    PENNINGTON, JE
    WHERRY, JC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 934 - 941
  • [2] MULTIPLE GROUP LOGISTIC DISCRIMINATION
    ALBERT, A
    LESAFFRE, E
    [J]. COMPUTERS & MATHEMATICS WITH APPLICATIONS-PART A, 1986, 12 (02): : 209 - 224
  • [3] ALBERT A, 1987, INTERPRETATION CLIN, P73
  • [4] AN OVERVIEW OF MORTALITY RISK PREDICTION IN SEPSIS
    BARRIERE, SL
    LOWRY, SF
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (02) : 376 - 393
  • [5] GRAM-NEGATIVE SEPSIS - A DILEMMA OF MODERN MEDICINE
    BONE, RC
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (01) : 57 - 68
  • [6] A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TO ENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL
    BONE, RC
    BALK, RA
    FEIN, AM
    PERL, TM
    WENZEL, RP
    REINES, HD
    QUENZER, RW
    IBERTI, TJ
    MACINTYRE, N
    SCHEIN, RMH
    TRENHOLME, G
    NIEDERMAN, M
    CHALFIN, D
    ABALOS, A
    OROPELLO, J
    EMPSON, P
    CAMINITII, S
    GREENMAN, R
    BOOTH, F
    PLOUFFE, J
    RUSSELL, J
    GIANAKOPOULOS, G
    IANNINI, P
    HINDES, R
    COBLENS, K
    KOHLER, R
    MARTIN, M
    BERNARD, G
    EDWARDS, J
    CRISLIP, M
    FILLER, S
    NASRAWAY, SA
    SIGEL, PK
    SOTTILE, FD
    MARTIN, DH
    DEBOISBLANC, BP
    CHANDRASEKAR, PH
    BROUGHTON, WA
    MIDDLETON, RM
    SEIBERT, AF
    EMMANUEL, G
    LIE, TH
    ANDERSON, CLV
    PANKEY, GA
    ANDERSON, P
    OLSEN, K
    SANPEDRO, GS
    GRAHAM, D
    GROSSMAN, J
    WELS, PB
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (06) : 994 - 1006
  • [7] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [8] SEPSIS AND CONTROLLED CLINICAL-TRIALS - THE ODYSSEY
    BONE, RC
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (07) : 1165 - 1166
  • [9] SEPSIS AND CONTROLLED CLINICAL-TRIALS - THE ODYSSEY CONTINUES
    BONE, RC
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (08) : 1313 - 1315
  • [10] INTERLEUKIN-8 IS A MAJOR NEUTROPHIL CHEMOTACTIC FACTOR IN PLEURAL LIQUID OF PATIENTS WITH EMPYEMA
    BROADDUS, VC
    HEBERT, CA
    VITANGCOL, RV
    HOEFFEL, JM
    BERNSTEIN, MS
    BOYLAN, AM
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (04): : 825 - 830